复方甘草酸苷在耐多药肺结核患者抗结核治疗过程中的保肝作用临床观察

目的观察复方甘草酸苷在耐多药肺结核患者化疗过程中的保肝作用。方法将68例耐多药肺结核化疗中肝损害患者随机分为治疗组36例、对照组32例,治疗组加用复方甘草酸苷,对照组加用肝太乐和益肝灵,观察2组治疗前、后的保肝作用和不良反应等。结果保肝治疗1mo后,治疗组和对照组保肝作用总有效率分别为94.4%、62.5%,二者比较具有显著性差异(P<0.01),不良反应发生率比较无显著性差异(P>0.05)。结论复方甘草酸苷用于耐多药肺结核肝功能损害患者保肝疗效可靠,不良反应少。

Clinical Observation on Hepatoprotective Effect of Compound Glycyrrhizin in Treating Patients with Multidrug Resistant Pulmonary Tuberculosis

OBJECTIVE:To observe the hepatoprotective effect of compound glycyrrhizin in treating patients with multidrug resistant pulmonary tuberculosis(MDR-TB).METHODS:A total of 68 MDR-TB cases were enrolled:36(treatment group) were randomly assigned to receive additional glycyrrhizin,and 32(control group) to receive additional glucurolactone and legalon,the hepatoprotective effects and side effects between 2 groups were compared before and after treatment.RESULTS:The total effective rates of the treatment group and the control group were 94.4% and 62.5%,respectively 1month after hepatoprotective treatment,and significant difference was noted between 2 groups(P<0.01),while no significant difference was noted between 2 groups in the incidence of adverse drug reactions(P>0.05).CONCLUSION:Compound glycyrrhizin has a reliable hepatoprotective efficacy and few adverse drug reactions in treating MDR-TB patients complicating with lesion of liver function.